Skip to content
Medical Health Aged Care

Dementia Australia welcomes new appointment of Age Discrimination Commissioner

Dementia Australia 2 mins read

Dementia Australia welcomes the appointment of Mr Robert Fitzgerald AM as the next Age Discrimination Commissioner.

 

The Age Discrimination Commissioner, operating within the Australian Human Rights Commission, leads the work to prevent age-based discrimination and promote equality across areas of employment, education, accommodation and the provision of goods and services.

 

In this position, Mr Fitzgerald will spearhead initiatives to combat age related disparities and to advocate for the rights of older people in Australia.

 

Mr Fitzgerald contributed to the Dementia-Friendly Communities Roundtable in NSW Parliament in September 2022 which resulted in the inaugural NSW Parliamentary Friends of Dementia Action Plan 2023-2025 released in September 2023.

 

Dementia Australia Executive Director, Services, Advocacy and Research Dr Kaele Stokes said the appointment was well deserved.

 

“Mr Fitzgerald has long championed the rights of older people, including those with a cognitive impairment, and this new appointment acknowledges his commitment to serving this community,” Dr Stokes said.

 

“In 2024 there are more than 421,000 people living with all forms of dementia in Australia. Without a medical breakthrough, the number of people is expected to increase to more than 812,500 by 2054.

 

“Older people living with dementia are more susceptible to elder abuse, including physical, emotional, psychological, sexual, social and financial abuse as well as neglect.

 

“Dementia Australia looks forward to working with Mr Fitzgerald to protect older Australians, especially people living with dementia or cognitive impairment who are more vulnerable within the community.”

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

-Ends-

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Media contacts: Sally Grandy, Senior Media and Communications Advisor, 0401 566710, Sally.Grandy@dementia.org.au

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.


Contact details:

Sally Grandy, Senior Media and Communications Advisor - 0401 566710

More from this category

  • Medical Health Aged Care
  • 15/06/2024
  • 04:30
Dementia Australia

Join us TODAY for Hunter Walk & Jog

What: Dementia Australia’sHunterMemory Walk & Jog. When: Saturday 15 June from 7.30am. Who: More than 750 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Speers Point Park, Speers Point For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support…

  • Contains:
  • Medical Health Aged Care
  • 14/06/2024
  • 22:07
Takeda Pharmaceutical Company Limited

Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

− Takeda to Receive Exclusive Option to License Global Rights to Olverembatinib in All Territories Outside of Mainland China, Hong Kong, Macau, Taiwan and…

  • Contains:
  • Disability, Medical Health Aged Care
  • 14/06/2024
  • 09:44
Audika

NEGLECTED SENSE: 73% ADMIT HEARING FALLS BEHIND SIGHT IN ATTENTION

A new survey commissioned by hearing care expertsAudika Hearing Clinic reveals surveyed Australians prioritise their sight over hearing, despite over three quarters (77%) knowing someone who is hard of hearing. Most (86%) respondents ranked sight as their most important sense, with hearing coming in second (69%)[1]. Unsurprisingly, this is reflected in which sense they care for more, with almost three quarters (73%) of respondents admitting that between hearing and sight, their hearing was the most neglected[1]. Reasons for neglect: Lack of understanding and stigma Both stigma and a lack of understanding can impact the way Australians prioritise their senses. Interestingly,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.